Exposure and ecotoxicological risk assessment of mixtures of top prescribed pharmaceuticals in Swedish freshwaters.

Surface water concentrations of 54 pharmaceuticals were predicted for seven major Swedish rivers and the Stockholm City area basins using the STREAM-EU model. These surface water concentrations were used to predict the ecotoxicological impact resulting from the exposure of aquatic organisms to this mixture of 54 pharmaceuticals. STREAM-EU model results indicated that <10 substances were present at median annual water concentrations greater than 10 ng/L with highest concentrations occurring mostly in the more densely populated area of the capital city, Stockholm. There was considerable spatial and temporal variability in the model predictions (1-3 orders of magnitude) due to natural variability (e.g. hydrology, temperature), variations in emissions and uncertainty sources. Local mixture ecotoxicological pressures based on acute EC50 data as well as on chronic NOEC data, expressed as multi-substance potentially affected fraction of species (msPAF), were quantified in 114 separate locations in the waterbodies. It was estimated that 5% of the exposed aquatic species would experience exposure at or above their acute EC50 concentrations (so-called acute hazardous concentration for 5% of species, or aHC5) at only 7% of the locations analyzed (8 out of 114 locations). For the evaluation based on chronic NOEC concentrations, the chronic HC5 (cHC5) is exceeded at 27% of the locations. The acute mixture toxic pressure was estimated to be predominantly caused by only three substances in all waterbodies: Furosemide, Tramadol and Ibuprofen. A similar evaluation of chronic toxic pressure evaluation logically demonstrates that more substances play a significant role in causing a higher chronic toxic pressure at more sites as compared to the acute toxic pressure evaluation. In addition to the three substances contributing most to acute effects, the chronic effects are predominantly caused by another five substances: paracetamol, diclofenac, ethinylestradiol, erythromycin and ciprofloxacin. This study provides regulatory authorities and companies responsible for water quality valuable information for targeting remediation measures and monitoring on a substance and location basis.

Model-predicted occurrence of multiple pharmaceuticals in Swedish surface waters and their flushing to the Baltic Sea.

An exposure assessment for multiple pharmaceuticals in Swedish surface waters was made using the STREAM-EU model. Results indicate that Metformin (27 ton/y), Paracetamol (6.9 ton/y) and Ibuprofen (2.33 ton/y) were the drugs with higher amounts reaching the Baltic Sea in 2011. 35 of the studied substances had more than 1 kg/y of predicted flush to the sea. Exposure potential given by the ratio amount of the drug exported to the sea/amount emitted to the environment was higher than 50% for 7 drugs (Piperacillin, Lorazepam, Metformin, Hydroxycarbamide, Hydrochlorothiazide, Furosemide and Cetirizine), implying that a high proportion of them will reach the sea, and below 10% for 27 drugs, implying high catchment attenuation. Exposure potentials were found to be dependent of persistency and hydrophobicity of the drugs. Chemicals with Log D > 2 had exposure potentials <10% regardless of their persistence. Chemicals with Log D  <  -2 had exposure potentials >35% with higher ratios typically achieved for longer half-lives. For Stockholm urban area, 17 of the 54 pharmaceuticals studied had calculated concentrations higher than 10 ng/L. Model agreement with monitored values had an r2 = 0.62 for predicted concentrations and an r2 = 0.95 for predicted disposed amounts to sea.

Evaluation of human pharmaceutical emissions and concentrations in Swedish river basins.

An emissions inventory for top consumed human pharmaceuticals in Sweden was done based on national consumption data, human metabolic rates and wastewater treatment removal rates. Concentrations of pharmaceuticals in surface waters in Swedish river basins were predicted using estimated emissions from the inventory and river discharges. Our findings indicate that the top ten emitted pharmaceuticals in our study set of 54 substances are all emitted in amounts above 0.5ton/y to both surface waters and soils. The highest emissions to water were in decreasing order for Metformin, Furosemide, Gabapentin, Atenolol and Tramadol. Predicted emissions to soils calculated with the knowledge that in Sweden sludge is mostly disposed to soil, point to the highest emissions among the studied drugs coming from, in decreasing order, Metformin, Paracetamol, Ibuprofen, Gabapentin and Atenolol. Surface water concentrations in Sweden's largest rivers, all located in low density population zones, were found to be below 10ng/L for all substances studied. In contrast, concentrations in surface waters in Stockholm's metropolitan area, the most populous in Sweden, surpassed 100ng/L for four substances: Atenolol, Metformin, Furosemide and Gabapentin.

Europe-wide estuarine export and surface water concentrations of PFOS and PFOA.

The STREAM-EU model was used to predict the water concentrations, estuarine export and retention of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in the eleven most populated European river catchments to provide a European-wide perspective on the contamination by these substances. Emissions of PFOS and PFOA to those catchments were calculated based on population, wealth and wastewater treatment plant (WWTP) coverage and efficiency using a previously published method and used as model input. Our estimated emissions showed the lowest values for the Thames catchment (PFOS: 0.4 ton/y; PFOA: 0.2 ton/y) and the highest values for the Rhine for PFOS (1.6 ton/y) and for the Dnieper for PFOA (1.7 ton/y). The model predicted concentrations agreed reasonable well with the existing range of measurements, apart from for PFOA in the River Po, where there is a known historical industrial contamination, and PFOS in the Rhone River, where results were much higher than the few measurements available. It was concerning that the model predicted that the surface water EQS for PFOS (0.65 ng/L) was exceeded by a wide margin in all the eleven studied European river catchments. The total calculated riverine export to the seas from the eleven catchments was 4.5 ton/y of PFOS and 3.7 ton/y of PFOA with highest exported quantities from the Rhine (PFOS: 1.0 ton/y; PFOA: 1.0 ton/y) and Danube estuaries (PFOS: 0.9 ton/y; PFOA: 0.7 ton/y). For the seas where the rivers discharge, riverine discharge of PFOS was estimated to be 2.5-30 times more important as an input than atmospheric deposition, whereas for PFOA the opposite was true (atmospheric deposition was 2-10 times more important) except for very small seas.

A large-scale model for simulating the fate & transport of organic contaminants in river basins.

We present STREAM-EU (Spatially and Temporally Resolved Exposure Assessment Model for EUropean basins), a novel dynamic mass balance model for predicting the environmental fate of organic contaminants in river basins. STREAM-EU goes beyond the current state-of-the-science in that it can simulate spatially and temporally-resolved contaminant concentrations in all relevant environmental media (surface water, groundwater, snow, soil and sediments) at the river basin scale. The model can currently be applied to multiple organic contaminants in any river basin in Europe, but the model framework is adaptable to any river basin in any continent. We simulate the environmental fate of perfluoroctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in the Danube River basin and compare model predictions to recent monitoring data. The model predicts PFOS and PFOA concentrations that agree well with measured concentrations for large stretches of the river. Disagreements between the model predictions and measurements in some river sections are shown to be useful indicators of unknown contamination sources to the river basin.

Estimating emissions of PFOS and PFOA to the Danube River catchment and evaluating them using a catchment-scale chemical transport and fate model.

Novel approaches for estimating the emissions of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) to surface waters are explored. The Danube River catchment is used to investigate emissions contributing to riverine loads of PFOS and PFOA and to verify the accuracy of estimates using a catchment-scale dynamic fugacity-based chemical transport and fate model (STREAM-EU; Spatially and Temporally Resolved Exposure Assessment Model for European basins). Model accuracy evaluation performed by comparing STREAM-EU predicted concentrations and monitoring data for the Danube and its tributaries shows that the best estimates for PFOS and PFOA emissions in the Danube region are obtained by considering the combined contributions of human population, wealth (based on local gross domestic product (GDP)) and wastewater treatment. Human population alone cannot explain the levels of PFOS and PFOA found in the Danube catchment waters. Introducing wealth distribution information in the form of local GDPs improves emission estimates markedly, likely by better representing emissions resulting from consumer trends, industrial and commercial sources. For compounds such as PFOS and PFOA, whose main sink and transport media is the aquatic compartment, a major source to freshwater are wastewater treatment plants. Introducing wastewater treatment information in the emission estimations also further improves emission estimates.